SSP and SOSA are honored to announce the Spring Cancer Conference, which will now be titled The Marjean Reed Cancer Conference in honor of Marjean Reed. This year’s topic is: The Structure of Survivorship: Comprehensive Care after Cancer. A keynote presentation will be given by Richard L. Deming, M.D., Radiation Oncologist and Medical Director at Mercy Cancer Center Radiation Oncology. Following his lecture there will be a panel discussion of health professionals and cancer survivors. Dinner will be served. Free annual cancer conference, open to the public. This conference is supported by: SGA, SOSA, Oncology Club, SOIMA, ACOFP, SOMA and student services.
Registration will be open until Monday, April 16.
Des Moines University students, staff, and faculty, Des Moines area physicians, nurses, social workers, other medical professionals, and the community.
Due to the lack of consensus of both the definition of cancer survivor and the appropriate care, education of both future and current healthcare providers regarding both these points is necessary. Further, because a multidimensional care program has been shown to be of benefit to cancer survivors, healthcare providers need to be aware of these benefits and utilize programs provided to them. The goal of this conference is to increase the awareness of survivor care and identify important interventions that can be utilized in order to provide quality patient care.
Upon completion of this activity, participants will be able to:
Keynote presentation, “Above and Beyond Cancer” Richard L. Deming, M.D.
Radiation Oncologist, Medical Director, Mercy Cancer Center Radiation
Dr. Deming indicated he has no financial relationships to disclose relevant to the content of this CME activity.
Dr. Deming came to Mercy Cancer Center Radiation Oncology in 1989 after spending two years on staff at the National Cancer Institute and National Naval Medical Center in Bethesda, Maryland. He is the medical director for Mercy Cancer Center Radiation Oncology and medical director of the CyberKnife Radiosurgery Center of Iowa. He also serves as the chairman of the Mercy Cancer Committee. Dr. Deming is active in a number of professional oncology organizations. He is president of the Iowa Society of Therapeutic Radiology. He serves on the Expert Panel for Radiation Oncology for the American College of Radiology. Dr. Deming is on the State Advisory Council of the American Cancer Society and is active in the Iowa Consortium for Comprehensive Cancer Care. He is on the board of directors for the Iowa Oncology Research Association and is the past chairman of the radiation oncology committee for the North Central Cancer Treatment Group. Dr. Deming is a charter member of the Des Moines chapter of the Lance Armstrong LiveStrong Foundation. He is also a Susan G. Komen Society “Doctor for the Cure” and actively supports breast cancer advocacy in Iowa. Dr. Deming is an avid adventurer. He enjoys running, cycling, swimming, triathlons, skiing and mountain climbing.
The panel members indicated they have no financial relationships to disclose relevant to the content of this CME activity.
There is no cost to attend but registration is strongly encouraged. Registration will be open until Monday, April 16.
The committee members indicated they have no financial relationships to disclose relevant to the content of this CME activity.
Educational grants are not being accepted for this activity.
AOA: Des Moines University and the AOA Council on Continuing Medical Education app
rove this program for a maximum of 1.0 hour of AOA Category 2-A and 1.5 hours of AOA Category 2-B hours.
IBON: Des Moines University Continuing Medical Education (provider #112) is approved by the Iowa Board of Nursing as an accredited provider. This program has been reviewed and approved for a maximum of 3.0 continuing education contact hours. Other: Attendees will be given a certificate of participation for a maximum 2.5 continuing education hours.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content for this program and the selection of speakers are responsibilities of the program director. Firms providing financial support did not have input in these areas. Des Moines University (DMU) prohibits discrimination in employment, educational programs, and activities on the basis of race, national origin, color, creed, religion, sex, age, disability, veteran status, sexual orientation, gender identity, or associational preference. The University also affirms its commitment to providing equal opportunities and equal access to University facilities. Individuals with disabilities are encouraged to attend DMU sponsored events. If you have questions/concerns, please contact Vanessa in the DMU Continuing Medical Education office at 515-271-1541 or email@example.com.